ACM

Aquilo Capital Management Portfolio holdings

AUM $37.1M
This Quarter Return
-17.63%
1 Year Return
-36.49%
3 Year Return
+1.32%
5 Year Return
+39.69%
10 Year Return
–
AUM
$179M
AUM Growth
+$179M
Cap. Flow
+$67.6M
Cap. Flow %
37.76%
Top 10 Hldgs %
88.91%
Holding
15
New
3
Increased
8
Reduced
2
Closed
1

Top Buys

1
ANAB icon
AnaptysBio
ANAB
$20.3M
2
NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$12.9M
3
ARWR icon
Arrowhead Research
ARWR
$12.6M
4
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
$11.4M
5
SPRO icon
Spero Therapeutics
SPRO
$5.36M

Top Sells

1
GLPG icon
Galapagos
GLPG
$5.43M
2
MRUS icon
Merus
MRUS
$3.25M
3
FATE icon
Fate Therapeutics
FATE
$1.41M

Sector Composition

1 Healthcare 87.31%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
QURE icon
1
uniQure
QURE
$920M
$23.8M 9.28%
501,975
+105,076
+26% +$4.99M
DRNA
2
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$22.7M 8.86%
1,237,379
+622,943
+101% +$11.4M
ANAB icon
3
AnaptysBio
ANAB
$578M
$20.3M 7.93%
+1,439,079
New +$20.3M
XENE icon
4
Xenon Pharmaceuticals
XENE
$3.02B
$17M 6.63%
1,499,970
+333,234
+29% +$3.78M
SPRO icon
5
Spero Therapeutics
SPRO
$115M
$14.7M 5.73%
1,818,140
+663,784
+58% +$5.36M
PRQR icon
6
ProQR Therapeutics
PRQR
$235M
$13.2M 5.14%
2,401,570
+479,000
+25% +$2.63M
NGM
7
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$12.9M 5.03%
+1,047,184
New +$12.9M
PVLA
8
Palvella Therapeutics, Inc. Common Stock
PVLA
$577M
$12.7M 4.95%
5,575,530
+608,710
+12% +$1.39M
ARWR icon
9
Arrowhead Research
ARWR
$3.51B
$12.6M 4.89%
+436,514
New +$12.6M
MRUS icon
10
Merus
MRUS
$5.02B
$9.32M 3.63%
770,183
-268,563
-26% -$3.25M
RGNX icon
11
Regenxbio
RGNX
$465M
$8.85M 3.45%
273,211
+4,433
+2% +$144K
GLPG icon
12
Galapagos
GLPG
$2.05B
$8.67M 3.38%
44,234
-27,733
-39% -$5.43M
MOR
13
DELISTED
MorphoSys AG American Depositary Shares
MOR
$2.36M 0.92%
95,898
+89,818
+1,477% +$2.21M
FATE icon
14
Fate Therapeutics
FATE
$118M
– –
-72,273
Closed -$1.41M
XBI icon
15
SPDR S&P Biotech ETF
XBI
$5.24B
– –
0
– –